MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardner, B.
Right arrow Articles by Sibley, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardner, B.
Right arrow Articles by Sibley, D. R.

Vol. 59, Issue 2, 310-321, February 2001

The Role of Phosphorylation/Dephosphorylation in Agonist-Induced Desensitization of D1 Dopamine Receptor Function: Evidence for a Novel Pathway for Receptor Dephosphorylation

Ben Gardner, Zhi Fang Liu, Dong Jiang, and David R. Sibley

Molecular Neuropharmacology Section, Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Exposure of D1 dopamine receptors to agonists results in rapid desensitization of the receptor-stimulated accumulation of cAMP. It is believed that agonist-induced phosphorylation of the receptor plays a critical role in the processes that underlie this phenomenon. To investigate the role of agonist-induced receptor phosphorylation, a FLAG epitope was added to the amino terminus of the rat D1 dopamine receptor and this construct was stably expressed in C6 glioma cells. It was found that the D1 receptor was stoichiometrically phosphorylated under basal conditions and that its phosphorylation state was increased by 2- to 3-fold upon exposure of the cells to dopamine for 10 min. The dopamine-induced receptor phosphorylation could be blocked by D1-selective antagonists but was unaffected by inhibitors of either protein kinase A or protein kinase C. The incorporation of phosphate into the receptor was rapid but transient, despite the continued presence of dopamine. A comparison of the rates of receptor phosphorylation (t1/2 < 1 min) and dopamine-induced desensitization (t1/2 ~7 min) revealed that receptor phosphorylation was not the rate limiting step for receptor desensitization. Upon removal of dopamine, the receptor was rapidly dephosphorylated (t1/2 ~10 min) and this was not blocked by agents (i.e., concanavalin A or hypertonic sucrose) that inhibit D1 receptor internalization. Using specific inhibitors, the phosphatase involved in D1 receptor dephosphorylation was shown not to correlate with the recently identified "G protein-coupled receptor phosphatase" (Proc Natl Acad Sci USA 92:8343-8347, 1995). These results suggest that the phosphorylated D1 receptor is processed through a novel recovery pathway and that internalization is not required for receptor dephosphorylation.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. H. So, V. Verma, B. F. O'Dowd, and S. R. George
Desensitization of the Dopamine D1 and D2 Receptor Hetero-Oligomer Mediated Calcium Signal by Agonist Occupancy of Either Receptor
Mol. Pharmacol., August 1, 2007; 72(2): 450 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Free, L. A. Hazelwood, D. M. Cabrera, H. N. Spalding, Y. Namkung, M. L. Rankin, and D. R. Sibley
D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin
J. Biol. Chem., July 20, 2007; 282(29): 21285 - 21300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. W. Jones, G. J. Song, E. K. Greuber, and P. M. Hinkle
Phosphorylation of the Endogenous Thyrotropin-releasing Hormone Receptor in Pituitary GH3 Cells and Pituitary Tissue Revealed by Phosphosite-specific Antibodies
J. Biol. Chem., April 27, 2007; 282(17): 12893 - 12906.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Sanchez-Laorden, C. Jimenez-Cervantes, and J. C. Garcia-Borron
Regulation of Human Melanocortin 1 Receptor Signaling and Trafficking by Thr-308 and Ser-316 and Its Alteration in Variant Alleles Associated with Red Hair and Skin Cancer
J. Biol. Chem., February 2, 2007; 282(5): 3241 - 3251.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. L. Rankin, P. S. Marinec, D. M. Cabrera, Z. Wang, P. A. Jose, and D. R. Sibley
The D1 Dopamine Receptor Is Constitutively Phosphorylated by G Protein-Coupled Receptor Kinase 4
Mol. Pharmacol., March 1, 2006; 69(3): 759 - 769.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. A. Neve
Novel Features of G Protein-Coupled Receptor Kinase 4
Mol. Pharmacol., March 1, 2006; 69(3): 673 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. W. Jones and P. M. Hinkle
{beta}-Arrestin Mediates Desensitization and Internalization but Does Not Affect Dephosphorylation of the Thyrotropin-releasing Hormone Receptor
J. Biol. Chem., November 18, 2005; 280(46): 38346 - 38354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Z. Wang, U. Hopfer, L. D. Asico, G. M. Eisner, R. A. Felder, and P. A. Jose
Rat Strain Effects of AT1 Receptor Activation on D1 Dopamine Receptors in Immortalized Renal Proximal Tubule Cells
Hypertension, October 1, 2005; 46(4): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Namkung and D. R. Sibley
Protein Kinase C Mediates Phosphorylation, Desensitization, and Trafficking of the D2 Dopamine Receptor
J. Biol. Chem., November 19, 2004; 279(47): 49533 - 49541.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose
Functional genomics of the dopaminergic system in hypertension
Physiol Genomics, November 17, 2004; 19(3): 233 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O.-J. Kim, B. R. Gardner, D. B. Williams, P. S. Marinec, D. M. Cabrera, J. D. Peters, C. C. Mak, K.-M. Kim, and D. R. Sibley
The Role of Phosphorylation in D1 Dopamine Receptor Desensitization: EVIDENCE FOR A NOVEL MECHANISM OF ARRESTIN ASSOCIATION
J. Biol. Chem., February 27, 2004; 279(9): 7999 - 8010.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Y. Luo, L. D. Asico, U. Hopfer, G. M. Eisner, R. A. Felder, and P. A. Jose
Perturbation of D1 Dopamine and AT1 Receptor Interaction in Spontaneously Hypertensive Rats
Hypertension, October 1, 2003; 42(4): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Chauvin, M. Bencsik, T. Bambino, and R. A. Nissenson
Parathyroid Hormone Receptor Recycling: Role of Receptor Dephosphorylation and {beta}-Arrestin
Mol. Endocrinol., December 1, 2002; 16(12): 2720 - 2732.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O.-J. Kim, M. A. Ariano, R. A. Lazzarini, M. S. Levine, and D. R. Sibley
Neurofilament-M Interacts with the D1 Dopamine Receptor to Regulate Cell Surface Expression and Desensitization
J. Neurosci., July 15, 2002; 22(14): 5920 - 5930.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. N. Mason, L. B. Kozell, and K. A. Neve
Regulation of Dopamine D1 Receptor Trafficking by Protein Kinase A-Dependent Phosphorylation
Mol. Pharmacol., April 1, 2002; 61(4): 806 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lamey, M. Thompson, G. Varghese, H. Chi, M. Sawzdargo, S. R. George, and B. F. O'Dowd
Distinct Residues in the Carboxyl Tail Mediate Agonist-induced Desensitization and Internalization of the Human Dopamine D1 Receptor
J. Biol. Chem., March 8, 2002; 277(11): 9415 - 9421.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics